Personalized medicine. Closing the gap between knowledge and clinical practice

被引:39
作者
Anaya, Juan-Manuel [1 ]
Duarte-Rey, Carolina [1 ]
Sarmiento-Monroy, Juan C. [1 ]
Bardey, David [2 ,3 ]
Castiblanco, John [1 ,4 ]
Rojas-Villarraga, Adriana [1 ]
机构
[1] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Carrera 26 63B-51, Bogota 111221, Colombia
[2] Univ Los Andes, Fac Econ Cede, Bogota, Colombia
[3] Toulouse Sch Econ, Toulouse, France
[4] Univ Rosario, Doctoral Program Biomed Sci, Bogota 111221, Colombia
关键词
Precision medicine; Pharmacogenomics; Autoimmune ecology; Rheumatoid arthritis; Type; 1; diabetes; Developing countries; PRIMARY BILIARY-CIRRHOSIS; ANTITUMOR NECROSIS FACTOR; TYPE-1; DIABETES-MELLITUS; LATIN-AMERICAN PATIENTS; RHEUMATOID-ARTHRITIS; VITAMIN-D; AUTOIMMUNE-DISEASES; PRIMARY PREVENTION; ADALIMUMAB TREATMENT; BRITISH-SOCIETY;
D O I
10.1016/j.autrev.2016.06.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Personalized medicine encompasses a broad and evolving field informed by a patient distinctive information and biomarker profile. Although terminology is evolving and some semantic interpretations exist (e.g., personalized, individualized, precision), in a broad sense personalized medicine can be coined as: "To practice medicine as it once used to be in the past using the current biotechnological tools." A humanized approach to personalized medicine would offer the possibility of exploiting systems biology and its concept of P5 medicine, where predictive factors for developing a disease should be examined within populations in order to establish preventive measures on at-risk individuals, for whom healthcare should be personalized and participatory. Herein, the process of personalized medicine is presented together with the options that can be offered in health care systems with limited resources for diseases like rheumatoid arthritis and type 1 diabetes. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:833 / 842
页数:10
相关论文
共 50 条
  • [21] Gender medicine. Sex- and gender-specific aspects of clinical medicine
    Kautzky-Willer, A.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2014, 57 (09) : 1022 - 1030
  • [22] Gender medicine. Sex- and gender-specific aspects of clinical medicine
    Kautzky-Willer, A.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2014, 57 (09) : 1022 - 1030
  • [23] Prescribing statins among patients with type 2 diabetes: The clinical gap between the guidelines and practice
    Hammad, Mohamed Anwar
    Suleiman, Syed Azhar Syed
    Aziz, Nor Azizah
    Noor, Dzul Azri Mohamed
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2019, 24
  • [24] Gap Between Official Guidelines and Clinical Practice for the Treatment of Rheumatoid Arthritis in Sao Paulo, Brazil
    de Camargo, Lara Alves
    Almeida Barros, Bruna Cipriano
    do Nascimento Silveira, Miriam Sanches
    Serpa Osorio-de-Castro, Claudia Garcia
    Guyatt, Gordon
    Lopes, Luciane Cruz
    CLINICAL THERAPEUTICS, 2016, 38 (05) : 1122 - 1133
  • [25] Clinical Zheng-hou Pharmacology: The Missing Link between Pharmacogenomics and Personalized Medicine?
    Yu, Ya-Nan
    Liu, Jun
    Zhang, Lei
    Wang, Zhong
    Duan, Dayue Darrel
    Wang, Yong-Yan
    CURRENT VASCULAR PHARMACOLOGY, 2015, 13 (04) : 423 - 432
  • [26] Clinical pharmacology and pharmacogenomics for implementation of personalized medicine
    Kamath, Ashwin
    Shenoy, Preethi
    Ullal, Sheetal
    Shenoy, Ashok
    Acharya, Sahana
    Shastry, Rajeshwari
    Rao, Rashmi
    Kamath, Priyanka
    Bharathi, Poovizhi
    Uppugunduri, Chakradhara Rao
    PHARMACOGENOMICS, 2023, : 873 - 879
  • [27] An eMERGE Clinical Center at Partners Personalized Medicine
    Smoller, Jordan W.
    Karlson, Elizabeth W.
    Green, Robert C.
    Kathiresan, Sekar
    MacArthur, Daniel G.
    Talkowski, Michael E.
    Murphy, Shawn N.
    Weiss, Scott T.
    JOURNAL OF PERSONALIZED MEDICINE, 2016, 6 (01): : 1 - 10
  • [28] Clinical and health economic challenges of personalized medicine
    Brueggenjuergen, B.
    Kornbluth, L.
    Ferrara, J. V.
    Willich, S. N.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2012, 55 (05) : 710 - 714
  • [29] Myocardial interstitial fibrosis in the era of precision medicine. Biomarker-based phenotyping for a personalized treatment
    Ravassa, Susana
    Gonzalez, Arantxa
    Bayes-Genis, Antoni
    Lupon, Josep
    Diez, Javier
    REVISTA ESPANOLA DE CARDIOLOGIA, 2020, 73 (03): : 247 - 253
  • [30] Nanomedicine and personalized medicine toward the application of pharmacotyping in clinical practice to improve drug-delivery outcomes'
    Vizirianakis, Ioannis S.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2011, 7 (01) : 11 - 17